Novavax, Inc. (NVAX) vs Precigen, Inc. (PGEN)

• Novavax, Inc. NVAX 9.51 ▼ −4.71%
• Precigen, Inc. PGEN 4.86 ▲ +2.97%

Novavax, Inc. and Precigen, Inc. are both Biotechnology companies. Novavax, Inc. and Precigen, Inc. are of similar size ($1.7B and $1.7B). Novavax, Inc. has negative trailing earnings, so its P/E is not meaningful; Precigen, Inc. trades at 63.8×. Precigen, Inc. grew revenue faster over the last twelve months: 2,387.6% against −61.3%. Precigen, Inc. has the higher net margin (15.6% vs −18.6%) and the higher return on invested capital (15.9% vs 0.00%). Across the 17 metrics below, Precigen, Inc. leads on 10 and Novavax, Inc. on 7.